share_log

Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors

DowjonesNews MarketWatch ·  Nov 25, 2021 05:52

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Quest Diagnostics Inc. (DGX) slipped 1.01% to $149.52 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.23% to 4,701.46 and the Dow Jones Industrial Average falling 0.03% to 35,804.38. The stock's fall snapped a three-day winning streak. Quest Diagnostics Inc. closed $11.04 below its 52-week high ($160.56), which the company reached on September 9th.

The stock underperformed when compared to some of its competitors Wednesday, as Laboratory Corp. of America Holdings (LH) fell 0.76% to $283.73, Qiagen N.V. (QGEN) fell 0.53% to $54.56, and Sonic Healthcare Ltd. ADR fell 0.20% to $29.83. Trading volume (719,297) remained 602,449 below its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 24, 2021.

-MarketWatch Automation

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment